Endoscopic evidence of GI hemorrhage induced by 5-fluorouracil administration

Gastrointestinal Endoscopy

Volumn 57, Issue 5, 2003, Pages 785-787

  Gizzi, Giuseppe C ^a,b   Biasco, Guido ^a   Villani, Valeria ^a   Corinaldesi, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTIBIOTIC AGENT; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; COLON ADENOCARCINOMA; DIARRHEA; DRUG WITHDRAWAL; ERADICATION THERAPY; FEVER; FLUID THERAPY; FOLLOW UP; GASTRECTOMY BILLROTH II; GASTRITIS; GASTRODUODENAL ULCER; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HEMATEMESIS; HUMAN; HYPEREMIA; INTESTINE INJURY; INTESTINE ULCER; MALE; NAUSEA; OUTCOMES RESEARCH; PEPTIC ULCER; PRIORITY JOURNAL; SIGMOIDECTOMY; STOMACH CANCER; STOMATITIS; VOMITING; CHEMOTHERAPY INDUCED EMESIS;

EID: 1142311476     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.214     Document Type: Article

References (15)

1. Moertel C, Fleming T, Macdonald J, Haller D, Laurie J, Tangen C. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-6.
2. Ansfield FJ, Shroeder JM, Cucreri AR. Five years clinical experience with 5-fluorouracil. JAMA 1962;181:295-9.
3. Kennedy BJ. 5-Fluorouracil toxicity. Cancer 1999;86:1099-100.
4. Lewis JH. Gastrointestinal injury due to medicinal agents. Am J Gastroenterol 1986;81:819-34.
5. Fata F, Ron IG, Kemeny N, O'Reilly E, Klimstra D, Kelsen DP. 5-Fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer 1999;86:1129-34.
6. Kelvin FM, Gramm HF, Gluck WL, Lokich JJ. Radiologic manifestations of small-bowel toxicity due to floxuridine therapy. AJM Am J Roentgenol 1986;146:39-43.
7. Lokich J. 5-Fluoruracil-induced small bowel, toxicity in patients with colorectal carcinoma. Cancer 2000;88:2045-6.
8. Shike M, Gillin JS, Kemeny N, Daly JM, Kurtz RC. Severe gastroduodenal ulcerations complicating hepatic artery infusion chemotherapy for metastatic colon cancer. Am J Gastroenterol 1986;81:176-9.
9. Chuang VP, Wallace S, Strohlein J. Hepatic artery infusion chemotherapy: gastroduodenal complications. AJM Am J Roentgenol 1981;137:347-50.
10. Hall DA, Clouse ME, Gramm HF. Gastroduodenal ulceration after hepatic arterial infusion chemotherapy. Am J Roentgenol 1981;136:1216-8.
11. Sartori S, Nielsen I, Maestri A, Beltrami D, Trevisani L, Pazzi P. Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Oncology 1991;48:356-61.
12. Tsurui M, Seki T, Seki M. Study on gastric mucosal lesions on lung cancer patients after chemotherapy. [in Japanese with English abstract]. Shokaki Naishikyo no Shinpo (Progress Digest Endoscopy) 1990;36:222-6.
13. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983;63:14-31.
14. Kuzel T, Esparaz B, Green D, Kies M. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 1990;65:885-9.
15. Kakinuma S, Ohwada S. Gastric mucosal blood flow and gastric secretion following intravenous administration of 5-fluorouracil in anesthetized rats. Cancer Chemother Pharmacol 1997;39:357-60.